Press Releases

May 31, 2022
SAN DIEGO --(BUSINESS WIRE)--May 31, 2022-- DexCom, Inc. (NASDAQ:DXCM) today issued the following statement in response to recent media and market speculation: “Like many companies, Dexcom’s Board and management team regularly review opportunities to enhance stockholder value and create benefits
May 23, 2022
SAN DIEGO --(BUSINESS WIRE)--May 23, 2022-- DexCom, Inc. (NASDAQ:DXCM) today announced that Brice Bobzien , Senior Vice President, Finance, will present an update on the company at the Piper Sandler Ophthalmology and Diabetes Symposium on Wednesday, May 25, 2022 at 1:00 p.m. (EDT) .
May 10, 2022
SAN DIEGO --(BUSINESS WIRE)--May 10, 2022-- DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain , Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor conferences: BofA Securities 2022 Healthcare Conference on
Apr 28, 2022
SAN DIEGO --(BUSINESS WIRE)--Apr. 28, 2022-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2022 . First Quarter 2022 Financial Highlights: Revenue grew 25% versus the same quarter of the prior year to $628.8 million on a reported basis
Apr 07, 2022
Report advances Dexcom’s environmental, social, and governance (ESG) transparency by providing new disclosures including company’s first Sustainability Accounting Standards Board (SASB) index SAN DIEGO --(BUSINESS WIRE)--Apr. 7, 2022-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time
Displaying 11 - 20 of 31